Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-9.89%
operating margin TTM
8.4%
revenue TTM
16.20 Billion
revenue per share TTM
14.14$
valuation ratios | |
|---|---|
| pe ratio | -10.52 |
| peg ratio | 0.15 |
| price to book ratio | 3.20 |
| price to sales ratio | 1.05 |
| enterprise value multiple | 3.45 |
| price fair value | 3.20 |
profitability ratios | |
|---|---|
| gross profit margin | 48.77% |
| operating profit margin | 8.4% |
| pretax profit margin | -7.76% |
| net profit margin | -9.89% |
| return on assets | -4.17% |
| return on equity | -26.12% |
| return on capital employed | 5.24% |
liquidity ratio | |
|---|---|
| current ratio | 0.98 |
| quick ratio | 0.75 |
| cash ratio | 0.26 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 129.41 |
| operating cycle | 196.86 |
| days of payables outstanding | 94.81 |
| cash conversion cycle | 102.05 |
| receivables turnover | 5.41 |
| payables turnover | 3.85 |
| inventory turnover | 2.82 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.46 |
| debt equity ratio | 3.36 |
| long term debt to capitalization | 0.75 |
| total debt to capitalization | 0.77 |
| interest coverage | 1.39 |
| cash flow to debt ratio | 0.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.20 |
| cash per share | 2.91 |
| operating cash flow per share | 1.64 |
| free cash flow operating cash flow ratio | 0.73 |
| cash flow coverage ratios | 0.10 |
| short term coverage ratios | 1.04 |
| capital expenditure coverage ratio | 3.73 |
Frequently Asked Questions
When was the last time Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported earnings?
Teva Pharmaceutical Industries Limited (TEVA) published its most recent earnings results on 29-01-2025.
What is Teva Pharmaceutical Industries Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Teva Pharmaceutical Industries Limited (NYSE:TEVA)'s trailing twelve months ROE is -26.12%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Teva Pharmaceutical Industries Limited (TEVA) currently has a ROA of -4.17%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TEVA's net profit margin stand at?
TEVA reported a profit margin of -9.89% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TEVA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.98 in the most recent quarter. The quick ratio stood at 0.75, with a Debt/Eq ratio of 3.36.